Azilsartan Kamedoxomil is Used for lowering blood pressure. It was first introduced by Azurity Pharmaceuticals Inc in its drug Edarbi on Feb 25, 2011. 2 different companies have introduced drugs containing Azilsartan Kamedoxomil.

Azilsartan Kamedoxomil Patents

Given below is the list of patents protecting Azilsartan Kamedoxomil, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Edarbi	US9066936	Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a pH control agent	Mar 26, 2028	Azurity
Edarbi	US7157584	Benzimidazole derivative and use thereof	May 22, 2025 (Expired)	Azurity
Edarbi	US7572920	Benzimidazole derivative and use as a II receptor antagonist	Jan 07, 2025 (Expired)	Azurity
Edarbi	US5958961	Pharmaceutical composition for angiotensin II-mediated diseases	Jun 06, 2014 (Expired)	Azurity
Edarbi	US5583141	Heterocyclic compounds and their use as angiotensin antagonists	Dec 10, 2013 (Expired)	Azurity

Add above patents to watchlist

Azilsartan Kamedoxomil's Family Patents

Full family tree

Azilsartan Kamedoxomil Generic API Manufacturers

Several generic applications have been filed for Azilsartan Kamedoxomil.

Given below is the list of companies who have filed for Azilsartan Kamedoxomil generic, along with the locations of their manufacturing plants worldwide.